Baird's Healthcare Team Delivers a Record First Half of 2026
Baird’s Healthcare group is striking on all cylinders with M&A and Equity Capital Markets activity at record levels and nicely balanced across all of our healthcare subsectors
Record Results. Accelerating Momentum.
Baird's Global Healthcare Group delivered a record first half of 2026, completing 17 M&A transactions representing more than $12 billion in transaction value and 14 public equity financings that raised over $10.7 billion in capital. Despite a challenging backdrop for both M&A and capital markets activity, our success reflects the strength of Baird's healthcare industry expertise, our exceptional transaction execution experience, our seamless industry and global collaboration and the continuity of our team.
Most importantly, the momentum continues to build. Supported by a backlog that is more than twice our record year-to-date results, we are exceptionally well positioned for a strong second half and believe our differentiated platform will continue to drive outstanding outcomes for clients throughout the remainder of 2026.
H1 2026 Highlights
- 17 Signed or closed Healthcare M&A Transactions
- $12+ Billion in M&A Transaction Value
- 14 Public Equity Financings, Raising $10.7 Billion of Capital
Select 2026 Healthcare Transactions
SAVE THE DATE:
2026 Global Healthcare Conference
Don’t miss our upcoming Global Healthcare Conference at the InterContinental New York Barclay on September 15, 2026. The conference brings together institutional and private equity investors with senior management from nearly 100 public and privately held companies for idea sharing, presentations and networking. Reach out to your Baird representative for additional details.
2026
Global Healthcare Conference
Wednesday, September 9 - Thursday, September 10
VIRTUAL PRIVATE COMPANY TRACK
Tuesday, September 15
INTERCONTINENTAL NEW YORK BARCLAY